Future medicinal chemistry

New thiazolone compounds as blockers of sugar-digesting enzymes and inflammation

Updated

Abstract

The new thiazole derivatives showed significant potential as alpha-glucosidase inhibitors, particularly compounds 3, 5, and 7.

  • Compounds 3, 5, and 7 demonstrated the strongest inhibition of alpha-glucosidase activity in vitro compared to the control.
  • Compounds 4 and 7 were identified as the most effective alpha-amylase inhibitors, with ICscore values approaching that of the control (Acarbose).
  • Compound 4 exhibited a lower ferric-reducing antioxidant power (FRAP) value compared to ascorbic acid in control experiments.
  • Molecular docking studies indicated favorable binding affinity and modes for compounds 4 and 5 at the alpha-glucosidase and alpha-amylase binding sites.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free